scholarly journals Varicella-zoster virus ORF1 gene product is a tail-anchored membrane protein localized to plasma membrane and trans-Golgi network in infected cells

Virology ◽  
2008 ◽  
Vol 377 (2) ◽  
pp. 289-295 ◽  
Author(s):  
Tetsuo Koshizuka ◽  
Tomohiko Sadaoka ◽  
Hironori Yoshii ◽  
Koichi Yamanishi ◽  
Yasuko Mori
1995 ◽  
Vol 69 (12) ◽  
pp. 7951-7959 ◽  
Author(s):  
Z Zhu ◽  
M D Gershon ◽  
Y Hao ◽  
R T Ambron ◽  
C A Gabel ◽  
...  

1994 ◽  
Vol 68 (10) ◽  
pp. 6372-6390 ◽  
Author(s):  
A A Gershon ◽  
D L Sherman ◽  
Z Zhu ◽  
C A Gabel ◽  
R T Ambron ◽  
...  

2017 ◽  
Vol 32 (5) ◽  
pp. 387-395 ◽  
Author(s):  
Wei Wang ◽  
Wenkun Fu ◽  
Dequan Pan ◽  
Linli Cai ◽  
Jianghui Ye ◽  
...  

2020 ◽  
Vol 94 (16) ◽  
Author(s):  
James H. Girsch ◽  
Wallen Jackson ◽  
John E. Carpenter ◽  
Thomas O. Moninger ◽  
Keith W. Jarosinski ◽  
...  

ABSTRACT The literature on the egress of different herpesviruses after secondary envelopment is contradictory. In this report, we investigated varicella-zoster virus (VZV) egress in a cell line from a child with Pompe disease, a glycogen storage disease caused by a defect in the enzyme required for glycogen digestion. In Pompe cells, both the late autophagy pathway and the mannose-6-phosphate receptor (M6PR) pathway are interrupted. We have postulated that intact autophagic flux is required for higher recoveries of VZV infectivity. To test that hypothesis, we infected Pompe cells and then assessed the VZV infectious cycle. We discovered that the infectious cycle in Pompe cells was remarkably different from that of either fibroblasts or melanoma cells. No large late endosomes filled with VZV particles were observed in Pompe cells; only individual viral particles in small vacuoles were seen. The distribution of the M6PR pathway (trans-Golgi network to late endosomes) was constrained in infected Pompe cells. When cells were analyzed with two different anti-M6PR antibodies, extensive colocalization of the major VZV glycoprotein gE (known to contain M6P residues) and the M6P receptor (M6PR) was documented in the viral highways at the surfaces of non-Pompe cells after maximum-intensity projection of confocal z-stacks, but neither gE nor the M6PR was seen in abundance at the surfaces of infected Pompe cells. Taken together, our results suggested that (i) Pompe cells lack a VZV trafficking pathway within M6PR-positive large endosomes and (ii) most infectious VZV particles in conventional cell substrates are transported via large M6PR-positive vacuoles without degradative xenophagy to the plasma membrane. IMPORTANCE The long-term goal of this research has been to determine why VZV, when grown in cultured cells, invariably is more cell associated and has a lower titer than other alphaherpesviruses, such as herpes simplex virus 1 (HSV1) or pseudorabies virus (PRV). Data from both HSV1 and PRV laboratories have identified a Rab6 secretory pathway for the transport of single enveloped viral particles from the trans-Golgi network within small vacuoles to the plasma membrane. In contrast, after secondary envelopment in fibroblasts or melanoma cells, multiple infectious VZV particles accumulated within large M6PR-positive late endosomes that were not degraded en route to the plasma membrane. We propose that this M6PR pathway is most utilized in VZV infection and least utilized in HSV1 infection, with PRV’s usage being closer to HSV1’s usage. Supportive data from other VZV, PRV, and HSV1 laboratories about evidence for two egress pathways are included.


2000 ◽  
Vol 74 (14) ◽  
pp. 6600-6613 ◽  
Author(s):  
Zuo-Hong Wang ◽  
Michael D. Gershon ◽  
Octavian Lungu ◽  
Zhenglun Zhu ◽  
Anne A. Gershon

ABSTRACT The trans-Golgi network (TGN) is putatively the site where varicella-zoster virus is enveloped. gE is targeted to the TGN by selective retrieval from the plasmalemma in response to signaling sequences in its endodomain. gI lacks these sequences but forms a complex with gE. We now find that gI is targeted to the TGN and plasma membrane when expressed in Cos-7 cells; nevertheless, surface labeling revealed that gI is not retrieved from the plasma membrane. TGN targeting of gI depended on the T338 of its endodomain and was lost when T338 was deleted or mutated to A, S, or D. The endodomain of gI was sufficient, if it contained T338, to target a fusion protein containing the ectodomain of the human interleukin-2 receptor to the TGN. A truncated protein consisting only of the gI ectodomain was secreted and taken up by nontransfected cells. This uptake of the secreted gI ectodomain was blocked by mannose 6-phosphate. Following cotransfection, both gI and gE were retrieved to the TGN from the plasma membrane in 26.7% of cells, neither gI nor gE was internalized in 18.3%, and gE was retrieved to the TGN while gI remained at the plasma membrane in 55%. We suggest that the T338 of its endodomain is necessary to retain gI in the TGN; moreover, because gI and gE interact, the signaling sequences of each glycoprotein reinforce one another in ensuring that both glycoproteins are concentrated in the TGN yet remain on the cell surface.


2012 ◽  
Vol 24 (7) ◽  
pp. 3074-3086 ◽  
Author(s):  
Elena Feraru ◽  
Mugurel I. Feraru ◽  
Rin Asaoka ◽  
Tomasz Paciorek ◽  
Riet De Rycke ◽  
...  

Vaccines ◽  
2021 ◽  
Vol 9 (12) ◽  
pp. 1440
Author(s):  
Han Cao ◽  
Yunfei Wang ◽  
Ning Luan ◽  
Kangyang Lin ◽  
Cunbao Liu

Glycoprotein E (gE) is one of the most abundant glycoproteins in varicella-zoster virus and plays pivotal roles in virus replication and transmission between ganglia cells. Its extracellular domain has been successfully used as an antigen in subunit zoster vaccines. The intracellular C-terminal domain was reported to be decisive for gE trafficking between the endoplasmic reticulum, trans-Golgi network and endosomes and could influence virus spread and virus titers. Considering that the trafficking and distribution of mRNA vaccine-translated gE may be different from those of gE translated against the background of the viral genome (e.g., most gE in virus-infected cells exists as heterodimers with another glycoprotein, gI,), which may influence the immunogenicity of gE-based mRNA vaccines, we compared the humoral and cellular immunity induced by LNP-encapsulated mRNA sequences encoding the whole length of gE, the extracellular domain of gE and a C-terminal double mutant of gE (mutant Y569A with original motif AYRV, which targets gE to TGN, and mutants S593A, S595A, T596A and T598A with the original motif SSTT) that were reported to enhance virus spread and elevate virus titers. The results showed that while the humoral and cellular immunity induced by all of the mRNA vaccines was comparable to or better than that induced by the AS01B-adjuvanted subunit vaccines, the C-terminal double mutant of gE showed stable advantages in all of the indicators tested, including gE-specific IgG titers and T cell responses, and could be adopted as a candidate for both safer varicella vaccines and effective zoster vaccines.


Sign in / Sign up

Export Citation Format

Share Document